AI nearly twice as good as biopsy at assessing rare cancer

AI could be nearly twice as accurate as biopsies at assessing the aggressiveness of some rare types of cancer, a new study suggests. According to researchers this could save the lives of thousands of patients. A research team from the Royal Marsden NHS Foundation Trust and the Institute for Cancer Research (ICR) focused on retroperitoneal sarcoma — a form of soft tissue sarcoma that develops in the back of the abdomen. “There is an urgent need to improve the diagnosis …

cancer corporates and innovation deep tech foundation good institute nhs patients research researchers research team save startups and technology study team trust types